Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice

Recombinant lipidated dengue-3 envelope protein domain III stimulates broad immune responses in mice

(2016) Chen-Yi Chiang et al.   VACCINE

A novel tetravalent formulation combining the four aggregated domain III-capsid proteins from dengue viruses induces a functional immune response in mice and monkeys

(2015) Edith Suzarte et al.   INTERNATIONAL IMMUNOLOGY

Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity

(2015) Louis Lau et al.   JOURNAL OF CLINICAL VIROLOGY

Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease

(2015) Sri Rezeki Hadinegoro et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America

(2015) Luis Villar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Tetravalent dengue DIIIC protein together with alum and ODN elicits a Th1 response and neutralizing antibodies in mice

(2015) Roland Zuest et al.   VACCINE

Epidemiological Trends of Dengue Disease in Colombia (2000-2011): A Systematic Review

(2015) Luis Angel Villar et al.   PLoS Neglected Tropical Diseases

The Immunodominance Change and Protection of CD4+ T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice

(2015) Hsin-Wei Chen et al.   PLoS One

The Human CD8+T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes

(2014) Daniela Weiskopf et al.   JOURNAL OF VIROLOGY

Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial

(2014) Maria Rosario Capeding et al.   LANCET

Recombinant lipidated dengue-4 envelope protein domain III elicits protective immunity

(2014) Chen-Yi Chiang et al.   VACCINE

Epidemiological Trends of Dengue Disease in Thailand (2000–2011): A Systematic Literature Review

(2014) Kriengsak Limkittikul et al.   PLoS Neglected Tropical Diseases

Recent Epidemiological Trends of Dengue in the French Territories of the Americas (2000–2012): A Systematic Literature Review

(2014) Maïna L'Azou et al.   PLoS Neglected Tropical Diseases

Epidemiology of Dengue Disease in the Philippines (2000–2011): A Systematic Literature Review

(2014) Lulu Bravo et al.   PLoS Neglected Tropical Diseases

Epidemiological Trends of Dengue Disease in Mexico (2000–2011): A Systematic Literature Search and Analysis

(2014) Héctor Gómez Dantés et al.   PLoS Neglected Tropical Diseases

Epidemiology of Dengue Disease in Malaysia (2000–2012): A Systematic Literature Review

(2014) Abdul Hamid Mohd-Zaki et al.   PLoS Neglected Tropical Diseases

A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates

(2013) Hsin-Wei Chen et al.   ARCHIVES OF VIROLOGY

Dengue vaccine efficacy trial: does interference cause failure?

(2013) Sathyamangalam Swaminathan et al.   LANCET INFECTIOUS DISEASES

Induction of robust immunity by the emulsification of recombinant lipidated dengue-1 envelope protein domain III

(2013) Chen-Yi Chiang et al.   MICROBES AND INFECTION

The global distribution and burden of dengue

(2013) Samir Bhatt et al.   NATURE

Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells

(2013) D. Weiskopf et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Lipidated Dengue-2 Envelope Protein Domain III Independently Stimulates Long-Lasting Neutralizing Antibodies and Reduces the Risk of Antibody-Dependent Enhancement

(2013) Chen-Yi Chiang et al.   PLoS Neglected Tropical Diseases

Epidemiological Trends of Dengue Disease in Brazil (2000–2010): A Systematic Literature Search and Analysis

(2013) Maria Glória Teixeira et al.   PLoS Neglected Tropical Diseases

Correlation between Dengue-Specific Neutralizing Antibodies and Serum Avidity in Primary and Secondary Dengue Virus 3 Natural Infections in Humans

(2013) Andreas Puschnik et al.   PLoS Neglected Tropical Diseases

Dengue-1 Envelope Protein Domain III along with PELC and CpG Oligodeoxynucleotides Synergistically Enhances Immune Responses

(2012) Chen-Yi Chiang et al.   PLoS Neglected Tropical Diseases

Refining the Global Spatial Limits of Dengue Virus Transmission by Evidence-Based Consensus

(2012) Oliver J. Brady et al.   PLoS Neglected Tropical Diseases

Dengue vaccines: progress and challenges

(2011) Beth-Ann G Coller et al.   CURRENT OPINION IN IMMUNOLOGY

Protection from Secondary Dengue Virus Infection in a Mouse Model Reveals the Role of Serotype Cross-Reactive B and T Cells

(2011) S. Zompi et al.   JOURNAL OF IMMUNOLOGY

A Novel Single-Dose Dengue Subunit Vaccine Induces Memory Immune Responses

(2011) Chen-Yi Chiang et al.   PLoS One

The two component adjuvant IC31® potentiates the protective immunity induced by a dengue 2 recombinant fusion protein in mice

(2011) Lidice Bernardo et al.   VACCINE

CD4+ T Cells Are Not Required for the Induction of Dengue Virus-Specific CD8+ T Cell or Antibody Responses but Contribute to Protection after Vaccination

(2010) L. E. Yauch et al.   JOURNAL OF IMMUNOLOGY

A recombinant lipoprotein containing an unsaturated fatty acid activates NF-κB through the TLR2 signaling pathway and induces a differential gene profile from a synthetic lipopeptide

(2010) Chih-Hsiang Leng et al.   MOLECULAR IMMUNOLOGY

A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice

(2010) Olivia K.T. Block et al.   VACCINE

A Protective Role for Dengue Virus-Specific CD8+ T Cells

(2009) L. E. Yauch et al.   JOURNAL OF IMMUNOLOGY

A simple method for evaluating dengue vaccine effectiveness in mice based on levels of viremia caused by intraperitoneal injection of infected culture cells

(2009) Atsushi Yamanaka et al.   VACCINE

A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design

(2009) Hsin-Wei Chen et al.   VACCINE

Immunogenicity and protective efficacy of a recombinant fusion protein containing the domain III of the dengue 1 envelope protein in non-human primates

(2008) L BERNARDO et al.   ANTIVIRAL RESEARCH

A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity

(2008) Chih-Hsiang Leng et al.   MICROBES AND INFECTION

Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in mice

(2008) J. Pradeep Babu et al.   VACCINE

Immunological evaluation in nonhuman primates of formulations based on the chimeric protein P64k-domain III of dengue 2 and two components of Neisseria meningitidis

(2008) Iris Valdés et al.   VACCINE

Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever

(2008) Anna P. Durbin et al.   VIROLOGY